Antimutagenic effect of Phellinus rimosus (Berk) Pilat against chemical induced mutations of histidine dependent Salmonella typhimurium strains

Food and Chemical Toxicology

Volumn 49, Issue 10, 2011, Pages 2676-2680

  Ajith, T A ^a   Janardhanan, K K ^b  

^a AMALA INSTITUTE OF MEDICAL SCIENCES   (India)

^b AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

Antimutagenicity; Cancer chemoprevention; Genomic instability; Macro fungus; Mutagens

Indexed keywords

4 NITRO 1,2 PHENYLENEDIAMINE; ANTIMUTAGENIC AGENT; BENZO[A]PYRENE; DOXORUBICIN; FUNGAL EXTRACT; METHYLNITRONITROSOGUANIDINE; N (2 FLUORENYL)ACETAMIDE; PHELLINUS RIMOSUS EXTRACT; SODIUM AZIDE; UNCLASSIFIED DRUG;

AMES TEST; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIMUTAGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM COLONY; CHEMICAL MUTAGENESIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG ISOLATION; DRUG SCREENING; FUNGUS; GENE MUTATION; IN VITRO STUDY; MALE; MUTAGENIC ACTIVITY; NONHUMAN; PHELLINUS RIMOSUS; RAT; SALMONELLA TYPHIMURIUM;

ANIMALS; ANTIMUTAGENIC AGENTS; BASIDIOMYCOTA; MALE; MICROSOMES, LIVER; MUTAGENICITY TESTS; MUTAGENS; MUTATION; RATS; RATS, SPRAGUE-DAWLEY; SALMONELLA TYPHIMURIUM;

BACTERIA (MICROORGANISMS); FUNGI; MAMMALIA; PHELLINUS RIMOSUS; SALMONELLA TYPHIMURIUM;

EID: 80051874718     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.07.022     Document Type: Article

References (28)

1. Ajith T.A., Janardhanan K.K. Cytotoxic and antitumor activities of a polypore macro fungus, Phellinus rimosus (Berk) Pilat. J. Ethnopharmacol. 2003, 84:157-162.
2. Ajith, T.A., Janardhanan, K.K., in press. Phellinus rimosus (Berk.) Pilat attenuates 7,12-dimethylbenz[a]anthracene induced and croton oil promoted skin papilloma formation in mice. J. Exp. Therap. Oncol.
3. Ajith T.A., Soja M. A comparative study on the antimutagenicity of atorvastatin and lovastatin against directly acting mutagens. Cell Biol. Toxicol. 2006, 22:269-274.
4. Ajith T.A., Subin J.P., Jacob J., Sanjay P.S., Babitha N.V. Antimutagenic and antioxidant activities of a non-steroidal anti-inflammatory drug. Celecoxib. Clin. Exp. Physiol. Pharmacol. 2005, 32:888-893.
5. Ajith T.A., Janardhanan K.K. Antioxidant and antihepatotoxic activities of Phellinus rimosus (Berk) Pilat. J. Ethnopharmacol. 2002, 81:387-391.
6. Calistri D., Rengucci C., Seymour I., Lattuneddu A., Polifemo A.M., Monti F., Saragoni L., Amadori D. Mutation analysis of p53, K-ras and BRAF genes in colorectal cancer progression. J. Cell. Physiol. 2005, 204:484-488.
7. Cardador-Martinez A., Castano-Tostado E., Loarca-Pina G. Antimutagenic activity of natural phenolic compounds present in the common bean (Phaseolus vulgaris) against aflatoxin B1. Food Addit. Contam. Part A Chem. Anal. Control Exposure Risk Assess. 2002, 19:62-69.
8. DeBaun J.R., Smith J.Y.R., Miller E.C., Miller J.A. Reactivity in vivo of the carcinogen N-Hydroxy-2-acetylaminofluorene: increase by sulfate ion. Science 1970, 167:184-186.
9. De Flora S. Mechanisms of inhibitors of mutagenesis and carcinogenesis. Mutat. Res. 1998, 402:151-158.
10. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
11. Harbone, J.B., 1973. In: Harbone, J.B. (Ed.), Phytochemical methods. Chapman and Hall Ltd., London, pp. 33-80.
12. Koch W.H., Henrikson E.N., Kupchella E., Cebula T.A. Salmonella typhimurium strain TA100 differentiates several classes of carcinogens and mutagens by base substitution specificity. Carcinogenesis 1994, 15:79-88.
13. Lesko S.A., Caspary W., Lorentzen R., Ts'o P. Enzymatic formation of 6-oxobenzo[a]pyrene radical in rat liver homogenate from carcinogenic benzo[a]pyrene. Biochemistry 1975, 14:3978-3982.
14. Mao L., Sidransky D. Cancer screening based on genetic alterations in human tumors. Cancer Res. 1994, 54:1939-1940.
15. Mortelmans K., Zeiger E. The Ames Salmonella/microsome mutagenicity assay. Mutat. Res. 2000, 455:29-60.
16. Maron D.M., Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 1983, 113:173-215.
17. Quiros R.M., Ding H.G., Gattuso P., Prinz R.A., Xu X. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Cancer 2005, 103:2261-2268.
18. Rastogi S., Khanna S.K., Das M. A spectrophotometric method to monitor the catalytic activity of mirosomal cytochrome P-450 II BI/2: comparison with fluorometric assay. Ind. J. Biochem. Biophys. 2002, 39:191-196.
19. Shon M.Y., Choi S.D., Kahng G.G., Nam S.H., Sung N.J. Antimutagenic, antioxidant and free radical scavenging activity of ethyl acetate extracts from white, yellow and red onions. Food Chem. Toxicol. 2004, 42:659-666.
20. Shon Y.H., Nam K.S. Antimutagenic and induction of anticarcinogenic phase II enzymes by basidiomycetes. J. Ethnopharmacol. 2001, 77:103-109.
21. Singal P.K., Li T., Kumar D., Danelisen I., Hiskovic N. Adriamycin-induced heart failure: mechanism and modulation. Mol. Cell. Biochem. 2000, 207:77-86.
22. Singh B.N., Singh B.R., Singh R.L., Prakash D., Singh D.P., Sarma B.K., Upadhyay G., Singh H.B. Polyphenolics from various extracts/fractions of red onion (Allium cepa) peel with potent antioxidant and antimutagenic activities. Food Chem. Toxicol. 2009, 47:1161-1167.
23. Smith W.A., Gupta R.C. Use of a microsome-mediated test system to assess efficacy and mechanisms of cancer chemopreventive agents. Carcinogenesis 1996, 17:1285-1290.
24. Tahara E. Growth factors and oncogenes in human gastrointestinal carcinomas. J. Cancer Res. Clin. Oncol. 1990, 116:121-131.
25. Wagner, H., Bladt, S., Zgairski, E.M., 1984. In: Wagner, H., Bladt, S., Zgairski, E.M. (Eds.), Plant drug analysis. Springer-Verlag, Berling/New York. pp. 304.
26. Wasser S.P. Medicinal mushroom science: history, current status, future trends and unsolved problems. Int. J. Med. Mushr. 2010, 12:1-16.
27. Wright P.A., Williams G.T. Molecular biology and gastric carcinoma. Gut 1993, 34:145-147.
28. Yoon D.H., Lee W.H., Han S.K., Shresta B., Kim C.H., Lim M.H., Chang W., Lim S., Choi S., Song W.O., Sung J.M., Hwang K.C., Kim T.W. Phellinus linteus inhibits inflammatory mediators by suppressing redox-based NF-κB and MAPKs activation in lipopolysaccharide-induced RAW 264.7 macrophages. J. Ethnopharmacol. 2007, 114:307-315.